← Browse by Condition
Medical Condition

osteopenia

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for osteopenia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — osteopenia Clinical Trials

How many clinical trials are currently recruiting for osteopenia?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for osteopenia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for osteopenia?
osteopenia research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a osteopenia clinical trial?
Eligibility criteria for osteopenia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
Tufts Medical Center 1 trial
S.LAB (SOLOWAYS) 1 trial
Meyer Children's Hospital IRCCS 1 trial
Odense University Hospital 1 trial

Recruiting Clinical Trials

NCT07473713 Phase 1
Recruiting
Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia
Enrollment
60 pts
Location
United States
Sponsor
Tufts Medical Center
View Trial →
NCT06867952
Recruiting
A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant
Enrollment
40 pts
Location
Russia
Sponsor
S.LAB (SOLOWAYS)
View Trial →
NCT07412782
Recruiting
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
Enrollment
100 pts
Location
Italy
Sponsor
Meyer Children's Hospital IRCC...
View Trial →
NCT07191353 Phase 2
Recruiting
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
Enrollment
148 pts
Location
Denmark
Sponsor
Odense University Hospital
View Trial →

Related Conditions

osteoporosis (2) osteogenesis imperfecta (1) hypogonadisms (1) neoplasia (1) obesity overweight (1) malnutrition calorie (1) hypercortisolism (1) growth hormone deficiency ghd (1) healthy (1) osteoporosis risk (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology